An empirical method for splitting arcs in VMAT.

PURPOSE: We present a new approach to determine the optimal arc split for VMAT beams which is an extension of our recently published algorithm for selecting optimal beam angles in Intensity Modulated Radiation Therapy (IMRT) MATERIAL AND METHODS: The proposed approach uses an objective function based scoring method called "ψ - score" to determine optimal arc splitting strategy. To validate our approach, we applied it in different clinical cases: Abdomen-Para aortic node, Lung, Pancreas and Prostate. Basically, for all clinical cases, two set of plans were created, namely VMAT plan and VMAT_S plan using Pinnacle3 (V16.2, Philips Medical Systems (Cleveland), Inc.). In the VMAT plans, full arc (360°) with 4-degree gantry spacing was used during optimization to compute the "ψ - score". Subsequently the avoidable arc portions were identified and removed using the ψ - score plot followed by the final optimization (VMAT_S). RESULTS: Equivalent or better OAR sparing, and similar target coverage were achieved in VMAT_S plans compared to VMAT plans. VMAT_S reduced the number of control points and monitor units by 24.2% and 12.9% respectively. On the average, beam on time was reduced by 21.9% and low dose volume (5 Gy isodose volume) to healthy tissues was reduced by 4.9% in VMAT_S compared to VMAT plans. CONCLUSION: The results demonstrated that the proposed method is useful for reducing the monitor units, beam on time and low dose volume without significantly compromising plan quality and most useful for non-centrically located targets.

Objective function based ranking method for selection of optimal beam angles in IMRT.

We propose a novel method for the selection of optimal beam angles in Intensity Modulated Radiation Therapy (IMRT). The proposed approach uses an objective function based metric called "target-to-critical organ objective function ratio" to find out the optimal gantry angles. The beams are ranked based on this metric and are accordingly chosen for IMRT optimization. We have used the Pinnacle TPS (Philips Medical System V 16.2) for performing the IMRT optimization. In order to validate our approach, we have applied it in four clinical cases: Head and Neck, Lung, Abdomen and Prostate. Basically, for all clinical cases, two set of plans were created with same clinical objectives, namely Equal angle plan (EA Plan) and Suitable angle Plan (SA Plan). In the EA plans, the beam angles were placed in an equiangular manner starting from the gantry angle of 0°. In the corresponding SA plans, the beam angles were decided using the guidance provided by the algorithm. The reduction in OAR mean dose and max dose obtained in SA plans is about 3 to 16% and 3 to 15% respectively depending upon the treatment site while obtaining equal target coverage as compared to their EA counterparts. It takes approximately 15-25 min to find the optimal beam angles. The results obtained from the clinical cases indicate that the plan quality is considerably improved when the beam angles are optimized using the proposed method.

Crystal structure of 4,5,6,7,8,8-hexa-chloro-2-(3,4-di-meth-oxy-pheneth-yl)-3a,4,7,7a-tetra-hydro-1H-4,7-methano-iso-indole-1,3(2H)-dione [+solvent].

In the title compound, C19H15Cl6NO4 [+solvent], the six-membered ring of the norbornene moiety adopts a boat conformation and the two five-membered rings have envelope conformations. The pyrrolidine ring makes a dihedral angle of 14.83 (12)° with the 3,4-di-meth-oxy-phenyl ring, which are attached to each other by an extended N-CH2-CH2-Car bridge. In the crystal, the structure features C-H⋯O inter-molecular hydrogen bonds, an offset π-π inter-action [inter-centroid distance = 3.564 (1) Å] and a C-Cl⋯π inter-action. The contribution of some disordered solvent to the scattering was removed using the SQUEEZE routine [Spek (2015 ▸). Acta Cryst. C71, 9-18] of PLATON. The solvent contribution was not included in the reported mol-ecular weight and density.